| Sorafenib in advanced hepatocellular carcinoma JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, ... New England journal of medicine 359 (4), 378-390, 2008 | 15654 | 2008 |
| Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ... The lancet oncology 10 (1), 35-43, 2009 | 2295 | 2009 |
| Design and endpoints of clinical trials in hepatocellular carcinoma JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, ... Journal of the National Cancer Institute 100 (10), 698-711, 2008 | 2039 | 2008 |
| Gene expression in fixed tissues and outcome in hepatocellular carcinoma Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ... New England Journal of Medicine 359 (19), 1995-2004, 2008 | 1370 | 2008 |
| Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study JW Park, M Chen, M Colombo, LR Roberts, M Schwartz, PJ Chen, ... Liver International 35 (9), 2155-2166, 2015 | 1298 | 2015 |
| Resection and liver transplantation for hepatocellular carcinoma JM Llovet, M Schwartz, V Mazzaferro Seminars in liver disease 25 (02), 181-200, 2005 | 1148 | 2005 |
| α-fetoprotein, des-γ carboxyprothrombin, and lectin-bound α-fetoprotein in early hepatocellular carcinoma JA Marrero, Z Feng, Y Wang, MH Nguyen, AS Befeler, LR Roberts, ... Gastroenterology 137 (1), 110-118, 2009 | 920 | 2009 |
| Pivotal role of mTOR signaling in hepatocellular carcinoma A Villanueva, DY Chiang, P Newell, J Peix, S Thung, C Alsinet, V Tovar, ... Gastroenterology 135 (6), 1972-1983. e11, 2008 | 850 | 2008 |
| Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features D Sia, Y Jiao, I Martinez-Quetglas, O Kuchuk, C Villacorta-Martin, ... Gastroenterology 153 (3), 812-826, 2017 | 846 | 2017 |
| Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis P Tabrizian, G Jibara, B Shrager, M Schwartz, S Roayaie Annals of surgery 261 (5), 947-955, 2015 | 815 | 2015 |
| Focal gains of VEGFA and molecular classification of hepatocellular carcinoma DY Chiang, A Villanueva, Y Hoshida, J Peix, P Newell, B Minguez, ... Cancer research 68 (16), 6779-6788, 2008 | 790 | 2008 |
| Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma E Wurmbach, Y Chen, G Khitrov, W Zhang, S Roayaie, M Schwartz, I Fiel, ... Hepatology 45 (4), 938-947, 2007 | 747 | 2007 |
| A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma S Roayaie, IN Blume, SN Thung, M Guido, MI Fiel, S Hiotis, DM Labow, ... Gastroenterology 137 (3), 850-855, 2009 | 699 | 2009 |
| The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies J Ozao-Choy, G Ma, J Kao, GX Wang, M Meseck, M Sung, M Schwartz, ... Cancer research 69 (6), 2514-2522, 2009 | 618 | 2009 |
| Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes D Sia, Y Hoshida, A Villanueva, S Roayaie, J Ferrer, B Tabak, J Peix, ... Gastroenterology 144 (4), 829-840, 2013 | 608 | 2013 |
| Unsuspected osteomyelitis in diabetic foot ulcers: diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline LG Newman, J Waller, CJ Palestro, M Schwartz, MJ Klein, G Hermann, ... Jama 266 (9), 1246-1251, 1991 | 523 | 1991 |
| Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis S Roayaie, JD Schwartz, MW Sung, SH Emre, CM Miller, GE Gondolesi, ... Liver Transplantation 10 (4), 534-540, 2004 | 519 | 2004 |
| Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters S Roayaie, JS Frischer, SH Emre, TM Fishbein, PA Sheiner, M Sung, ... Annals of surgery 235 (4), 533-539, 2002 | 513 | 2002 |
| Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised … AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ... The lancet Respiratory medicine 8 (5), 453-460, 2020 | 501 | 2020 |
| Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma A Villanueva, Y Hoshida, C Battiston, V Tovar, D Sia, C Alsinet, ... Gastroenterology 140 (5), 1501-1512. e2, 2011 | 472 | 2011 |
